#Biofilchem 72 Tgt90 #GLAND #AJANTPHARM #LAURUSLABS #ERIS #stockBIOFILCHEM 72
TGT 90+
SL -
Return
Risk -
RR
Timeframe < 6M
NSE:BIOFILCHEM
Buy Recommended
Can hold for long term
Shared with 💚
By Rachit Sethia
ERIS
Eris looking attractive.Eris Lifesciences Ltd. is presently engaged in manufacturing and marketing of pharmaceutical products. It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. Apart from this, it has a portfolio of 112 Mother Brands across therapy areas. Eris Lifesciences Ltd CMP is 917.3.
The Negative aspects of the company are High Valuation (P.E. = 32.2), Declining annual net profit, declining cash from operations annual, FIIs are decreasing stake, MFs are decreasing stake, High promoter pledge, Promoter Holding decreasing. The positive aspects of the company are No debt.
Entry can be taken after closing above 936. Targets in the stock will be 952 and 972. The long-term target in the stock will be 988 and 1020. Stop loss in the stock should be maintained at Closing below 806.
The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
Eris Life BreakoutThe stock has broken out and retested, therefore may undergo a reversal rally. Trade is supported by Supports Nearby.
Risk Reward Ratio - 2:1
SL is placed below the support zone & the lower trendline. The target is placed near resistance.
ERIS Life ReversalThe stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby.
Risk Reward Ratio - 2:1
SL is placed below support zone & the lower trendline. The target is placed near resistance.
Market is bearish, so take positions carefully.
ERIS Medium to long Term IdeaERIS Life Sciences was first given at 644 it went upto 861.95 and has corrected substantially there after. Fresh entry above 734 closing Targets 768. 768 will be a major resistance. Crossing 768 the price can go to 795 and 815 levels.
Thus X/2 entry can be taken in the counter at 734 closing and X/2 after closing above 768.
Stop Loss should be at closing below 670.
Eris Life Reversal TradeThe stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby.
Risk Reward Ratio - 2:1
SL is placed below support zone & the lower trendline. The target is placed near resistance.
ERIS LIFESCIENCE - Symmetric Triangle PatternERIS Lifescience is trying to create a symmetric triangle pattern in 6 months timeframe and can possibly give a breakout in upward side considering the pharma sector still has a pending bull run. One can take a long position from 517 - 524 for a possible breakout. Targets should be - 546 - 588 - 588++
ERIS LIFESCIENCE BREAKOUTPLEASE SEE CHART FOR DETAILS
TARGET 1 : 650
TARGET 1 : 700
STOP LOSS : 520
**These are my personal observations. Please trade at your own risk.**
ERIS | Long it!
Eris Lifesciences has been forming a continuation pennant pattern.
MACD supports the statement.
[8} Next target 10%
